Insider · CIK 0001663758

McCourt Marion

CIK 0001663758 Name as filed on the most recent filing

Filed as McCourt Marion (48)

50 transaction lines · from 48 filings · filed 2020-10-06 to 2024-11-05 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

50 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-11-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 844,610, disposed Open Form 4 filing 0001968202-24-000132
2024-10-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 1,054,060, disposed Open Form 4 filing 0001968202-24-000129
2024-09-03 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 1,178,730, disposed Open Form 4 filing 0001968202-24-000125
2024-08-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 1,206,198, disposed Open Form 4 filing 0001883850-24-000040
2024-07-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 1,190,564, disposed Open Form 4 filing 0001968202-24-000106
2024-06-03 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 1,115,422, disposed Open Form 4 filing 0001968202-24-000100
2024-05-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 222,353, disposed Open Form 4 filing 0001883850-24-000018
2024-04-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 241,183, disposed Open Form 4 filing 0001968202-24-000089
2024-03-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 346,365, disposed Open Form 4 filing 0001968202-24-000083
2024-02-05 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 934,710, disposed Open Form 4 filing 0001968202-24-000052
2024-02-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 258,152, disposed Open Form 4 filing 0001968202-24-000046
2024-01-02 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 239,451, disposed Open Form 4 filing 0001883850-24-000004
2023-12-11 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 226,379, disposed Open Form 4 filing 0001883850-23-000088
2023-11-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 783,910, disposed Open Form 4 filing 0001883850-23-000079
2023-10-02 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 858,426, disposed Open Form 4 filing 0001968202-23-000035
2023-09-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 208,638, disposed Open Form 4 filing 0001968202-23-000033
2023-08-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 186,165, disposed Open Form 4 filing 0001968202-23-000019
2023-07-03 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 177,523, disposed Open Form 4 filing 0001968202-23-000017
2023-06-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 184,000, disposed Open Form 4 filing 0001883850-23-000072
2023-04-03 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 900,680, disposed Open Form 4 filing 0001968202-23-000005
2023-03-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 835,879, disposed Open Form 4 filing 0001883850-23-000053
2023-02-07 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 769,040, disposed Open Form 4 filing 0001883850-23-000043
2023-02-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 827,409, disposed Open Form 4 filing 0001883850-23-000029
2023-01-03 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 794,046, disposed Open Form 4 filing 0001883850-23-000021
2022-12-12 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 192,765, disposed Open Form 4 filing 0001883850-22-000123
2022-12-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 831,809, disposed Open Form 4 filing 0001883850-22-000103
2022-11-04 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 727,820, disposed Open Form 4 filing 0001883850-22-000090
2022-11-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 825,000, disposed Open Form 4 filing 0001883850-22-000085
2022-10-03 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 2 lines 775,929, disposed Open Form 4 filing 0001883850-22-000078
2022-09-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 635,382, disposed Open Form 4 filing 0001883850-22-000060
2022-08-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 639,683, disposed Open Form 4 filing 0001883850-22-000050
2022-07-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 646,536, disposed Open Form 4 filing 0001883850-22-000048
2022-06-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 736,461, disposed Open Form 4 filing 0001708138-22-000042
2022-05-02 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 722,667, disposed Open Form 4 filing 0001883850-22-000043
2022-04-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 701,820, disposed Open Form 4 filing 0001708138-22-000034
2022-03-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 615,390, disposed Open Form 4 filing 0001883850-22-000016
2022-02-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 607,460, disposed Open Form 4 filing 0001708138-22-000010
2022-01-03 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 625,000, disposed Open Form 4 filing 0001883850-22-000010
2021-12-13 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 224,673, disposed Open Form 4 filing 0001883850-21-000030
2021-12-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 639,130, disposed Open Form 4 filing 0001883850-21-000014
2021-11-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 640,000, disposed Open Form 4 filing 0001883850-21-000006
2021-10-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 576,750, disposed Open Form 4 filing 0001883850-21-000003
2021-09-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 674,720, disposed Open Form 4 filing 0001708138-21-000073
2021-08-02 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 577,120, disposed Open Form 4 filing 0001708138-21-000039
2021-07-01 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 556,600, disposed Open Form 4 filing 0001708138-21-000034
2021-06-07 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 511,650, disposed Open Form 4 filing 0001237899-21-000007
2021-05-07 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 495,630, disposed Open Form 4 filing 0001708138-21-000018
2020-10-05 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 600,000, disposed Open Form 4 filing 0001237899-20-000042
2020-08-20 S, Open-market sale Regeneron Pharmaceuticals, Inc.REGN 612,150, disposed Open Form 4 filing 0001237899-20-000042

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
S, Open-market sale
Open-market sale
Relationships on this page
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 0
  • Open-market sale 50
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. McCourt Marion, insider transactions. Retrieved 2026-08-22 from https://ebomi.com/insider/0001663758

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.